Drug Pipeline

JNJ-90301900 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04892173 JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC Carcinoma, Squamous Cell Recruiting
Phase 2
NCT06667908 A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation… Carcinoma, Non-Small-Cell Lung Recruiting
Phase 1/2
NCT07224152 NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer Locally-Advanced Non-Small Cell Lung Cancer Recruiting
Phase 1
NCT07219212 A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With… Squamous Cell Carcinoma of Head and Neck Recruiting
Sponsors Running JNJ-90301900 Trials
Johnson & Johnson Enterprise Innovation Inc. (3) M.D. Anderson Cancer Center (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (1)
Get alerts when JNJ-90301900 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free